Sign up
MCK

McKesson Corporation (NYSE: MCK)

Healthcare · Medical Distribution

——

Quote unavailable · Price data is temporarily unavailable.

Set alert

The Quantellect read. The borrow fee is 0.25%. Descriptive summary of the data on this page, not a recommendation.

Relative valuation—

—

MomentumOverbought

RSI (14) 71.0 (overbought above 70, oversold below 30)

Trend—

—

Short interest1.7% of float

FINRA settlement Oct 30, 2026

MCK price chart

Price — · As of —

Open full chart →
Price details unavailable for this range.

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First date—
Last date—
Open—
High—
Low—
Close—
Volume—
Plotted bars0

Plotted OHLCV bars

No price bars are available for this range.

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of —

Initial 6M price range summary
Range6M
First close—
Last close—
High—
Low—
Volume—
Open—
Previous close—
Day range—
52-week range—
Volume—
Average volume (30 calendar days)—
Market cap—
P/E (TTM)—
Forward P/E—
EPS (TTM)—
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

MCK · NYSE · USD

Split-adjusted · volume in shares

Price history unavailable

Notable price movement

— · Notable price movement not available

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide65High Tide—
Social Pulse

0 mentions in 24h

How the scores work →

Industry comparison

— · Industry comparison not available

Upcoming events

— · Upcoming events not available

Analyst consensus

— · Analyst consensus not available

Earnings history

EPS, last 8 quarters
EstimateBeatMissMatch
Fiscal periodEst.ActualResult
Q2 2026$10.75$10.44—
Q1 2026$9.54$5.15—
Annual 2026$11.57$38.38—
Q3 2025—$9.59—
Q2 2025$8.92$8.92—
Q1 2025—$6.25—
Annual 2025$9.83$25.72—
Q3 2024$7.99$6.95—

Smart-money activity

— · Smart-money activity not available

All smart-money activity →

News and press releases

All MCK news →

Company profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions;

CEO
Mr. Brian S. Tyler Ph.D.
Headquarters
Irving, TX, United States
Employees
41,600
IPO date
Nov 15, 1994
Sector
Healthcare
Industry
Medical Distribution

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.